<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/2731</identifier>
				<datestamp>2021-08-30T20:30:08Z</datestamp>
				<setSpec>bovine:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">A Comparison of two Mannheimia haemolytica vaccination strategies in freshly weaned southeastern feedlot heifers</dc:title>
	<dc:creator xml:lang="en">Rogers, Karen C.</dc:creator>
	<dc:creator xml:lang="en">Portillo, Thomas A.</dc:creator>
	<dc:creator xml:lang="en">Smialek, Dennis E.</dc:creator>
	<dc:creator xml:lang="en">Miles, Del G.</dc:creator>
	<dc:creator xml:lang="en">Lehenbauer, Terry W.</dc:creator>
	<dc:creator xml:lang="en">Smyth, Russell</dc:creator>
	<dc:subject xml:lang="en">bovine</dc:subject>
	<dc:subject xml:lang="en">feedlot</dc:subject>
	<dc:subject xml:lang="en">BRD</dc:subject>
	<dc:subject xml:lang="en">Mannheimia haemolytica toxoid</dc:subject>
	<dc:subject xml:lang="en">MLV vaccine</dc:subject>
	<dc:subject xml:lang="en">calves</dc:subject>
	<dc:subject xml:lang="en">feedlots</dc:subject>
	<dc:subject xml:lang="en">heifers</dc:subject>
	<dc:subject xml:lang="en">immunization</dc:subject>
	<dc:subject xml:lang="en">liveweight gain</dc:subject>
	<dc:subject xml:lang="en">vaccination</dc:subject>
	<dc:subject xml:lang="en">vaccines</dc:subject>
	<dc:description xml:lang="en">A total of 1,017 southeastern crossbred heifer calves (average weight 572 lb; 260 kg) were used to determine the effect of administering Pyramid® 5 and Presponse® SQ (Fort Dodge Animal Health, Overland Park, KS) as two separate injections (SEP), or as a combination product (COMB), on health and performance in a commercial feedlot setting. There were no significant differences (P&amp;gt;0.05) between the two vaccine treatments for morbidity, mortality, or realizers. The SEP group had significantly greater weight gain (P=0.05) and average daily gain (P&amp;lt;0.01) at reprocessing (day 119). These differences subsided by harvest. Hot carcass weights, estimated live-weights and average daily gains at the end of the feeding period were similar among the vaccination groups (P&amp;gt;0.05).</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2008-12-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/bovine/article/view/2731</dc:identifier>
	<dc:identifier>10.21423/bovine-vol43no1p27-31</dc:identifier>
	<dc:source xml:lang="en">The Bovine Practitioner; Vol. 43, No. 1 (2009 Spring); 27-31</dc:source>
	<dc:source>0524-1685</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/bovine/article/view/2731/7645</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2009 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
